Skip to playerSkip to main content
  • 5 minutes ago
A team of researchers from the Institute for Basic Science has pinpointed ERBB4 as a likely contributor to various Alzheimer’s-associated alterations in the brain. Investigations using mouse models revealed that irregular ERBB4 function in excitatory neurons correlated with excessive neuronal activity, synaptic disturbances, the presence of reactive glial cells, and cognitive impairments. The elimination of this receptor mitigated these consequences and diminished amyloid plaque accumulation. Additionally, the research group examined brain samples and transcriptomic information from 446 individuals, discovering that elevated ERBB4 levels were linked to Alzheimer’s pathology and diminished cognitive abilities. Ongoing studies are required to evaluate the safety of targeting this mechanism in patients.

Disclosure: This video contains stock footage and content created or enhanced using Al-assisted tools.
ai-generated

Category

🗞
News
Transcript
00:00Alzheimer's research may have uncovered a key link in the disease process.
00:04Scientists identified a receptor called ERBB4 in a small group of excitatory brain neurons.
00:10These neurons showed an abnormal molecular state early in Alzheimer's-like disease.
00:15The researchers found ERBB4 activity was linked to excessive brain activity and synapse loss.
00:22It also affected astrocytes and microglia, which helped maintain the brain.
00:26When scientists removed ERBB4 in mice, several harmful changes were reduced.
00:32Amyloid plaque levels also declined, while memory and spatial cognition improved.
00:37Researchers then examined brain data from 446 people.
00:41Higher ERBB4 expression was associated with greater Alzheimer's pathology and poorer cognitive performance.
00:48The findings also point to mTOR signaling as an important pathway.
00:52Scientists say ERBB4 is not the single cause of Alzheimer's disease,
00:57but it could help connect several disease processes occurring together.
01:01Further studies are needed to determine whether this mechanism can be safely targeted in patients.
01:06Disclosure.
01:07This video contains stock footage and content created or enhanced using AI-assisted tools.
01:12So there're a lot of changes in analyzing the brain.
01:12The pecan is more of a THERE tongue.
01:12There's an excellent mandate for you.
Comments

Recommended